RxDoctor Payments Data

Katherine Kiger, DO

Family Medicine · Athens, OHNPI 1790013720

Payments from drug & device makers

$412in general payments, 2019–2025

Across 24 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$70
  • AbbVie$48
  • Lilly USA, LLC$36
  • Amgen$36
  • Otsuka America Pharmaceutical, Inc.$34
  • Pfizer$34
  • plus $154 from 8 others

What the payments were for

  • Food & beverage$412100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$412 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$43,943
Medicare patients
191
Services billed
669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$102,842
EliquisApixaban85$91,916
Humira PenAdalimumab13$88,552
FarxigaDapagliflozin Propanediol55$64,594
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$60,887
JanuviaSitagliptin Phosphate48$50,037
JardianceEmpagliflozin27$40,855
MounjaroTirzepatide24$34,678
TrulicityDulaglutide29$33,186
LinzessLinaclotide35$30,850
Combivent RespimatIpratropium/Albuterol Sulfate39$22,679
Symlinpen 60Pramlintide Acetate14$14,267
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen580$12,915
Spiriva RespimatTiotropium Bromide15$12,238
SymbicortBudesonide/Formoterol Fumarate28$11,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$34$102,84265 claims
PfizerEliquis$34$91,91685 claims
AstraZenecaFarxiga, Symbicort$70$76,40383 claims
Lilly USA, LLCMounjaro, Trulicity$36$67,86453 claims
GSKTrelegy Ellipta$14$60,88759 claims
AbbVieLinzess, Synthroid$48$32,89198 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Athens

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →